… the commonly used drugs used to treat the disease such as Suramin and … toxic in cancer
cells than the aglycone and 6 times less toxic in mice.[110] 18fluoro-2-deoxyglucose (FDG) has …

… provide … neuronal cells, from hepatocytes to adipose cells have further shown the exquisite
role of HuR in regulating many aspects of cellular differentiation and functions in various cell …

… The whole structure of MRP1, three TMDs with two NBDs, forms a stable network to ensure
… coupled to ATP hydrolysis which provides the required energy to expel substrate drugs to the …

… Therefore, despite the existence of several therapeutic drugs… low toxicity on HAF (normal
human fibroblasts). The … as a DNA interactive cytotoxic representative for colon cancer therapy. …

… Since our research group has been actively involved in the … Suramin is the first discovered
drug, it is an ureidic derivative with a … is to obtain a lower toxicity and reduced side effects. …

… in human THP-1 AML and HCT116 colon cancer cell lines … of lipofuscin-like granules into
a less toxic form. For the peer-… protease, 3CL pro , by suramin and quinacrine, 27 have made …

… therapy can increase the sensitivity of colorectal cancer cells by … provides a new treatment
for metabolic syndrome, cell … 11 was superior in terms of toxicity and specificity problems, and …

… due to their low toxicity, low drug resistance, low cost and … used as preventive and therapeutic
agents in cancer therapy. These … In this study, it has been shown that esculetin provides a …

… selective toxicity between normal astrocytes and glioma cells … Since the simultaneous
inhibition of SIRT1 and -2 has been … The human colon cancer cell line HCT116 p53 wild-type and …

… models, has been reported as a potential anti-tumor agent due … , stability, toxicity etc., which
form bottlenecks in the therapeutic … between two groups were assessed using the t-test. To …